In vitro and in vivo antileishmanial activities of Pistacia vera essential oil by Mahmoudvand, Hossein. et al.
Abstract
!
This study aims to evaluate the in vitro and in vivo
antileishmanial activities of Pistacia vera essential
oil and compare their efficacy with a reference
drug, meglumine antimoniate (Glucantime®).
This essential oil (0–100 µg/mL) was evaluated in
vitro against the intracellular amastigote forms of
Leishmania tropica (MHOM/IR/2002/Mash2) and
then tested on cutaneous leishmaniasis of male
BALB/c mice by Leishmania major (MRHO/IR/75/
ER). In the in vitro assay, it could be observed that
P. vera essential oil significantly (p < 0.05) inhib-
ited the growth rate of amastigote forms (IC50 of
21.3 ± 2.1 µg/mL) in a dose-dependent response
comparedwith the control drug. Meglumine anti-
moniate also demonstrated antileishmanial ef-
fects with an IC50 value of 44.6 ± 2.5 µg/mL for this
clinical stage. In the in vivo assay, the results indi-
cated that 30mg/mL of the essential oil had po-
tent suppression effects on cutaneous leishmani-
asis in BALB/c mice (87.5% recovery), while 10
and 20mg/mL of the essential oil represented
the suppression effects as weak to intermediate.
Themean diameter of the lesions decreased about
0.11 and 0.27 cm after the treatment of the sub-
groups with the essential oil concentrations of 10
and 20mg/mL, respectively. In contrast, in the
subgroup treatedwith the essential oil concentra-
tion of 30mg/mL, the mean diameter of the le-
sions decreased about 0.56 cm. In the control sub-
groups, the mean diameter of the lesions in-
creased to 1.01 cm. Themain components of P. ve-
ra essential oil were limonene (26.21%), α-pinene
(18.07%), and α-thujene (9.31%). It was also found
that P. vera essential oil had no significant cyto-
toxic effect on J774 cells. The present study found
that P. vera essential oil showed considerable in
vitro and in vivo effectiveness against L. tropica
and L. major compared to the reference drug.
These findings also provided the scientific evi-
dence that natural plants could be used in tradi-
tional medicine for the prevention and treatment
of cutaneous leishmaniasis.
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l.Introduction
!
Cutaneous leishmaniasis (CL) is a protozoan infec-
tion caused by protozoa of the genus Leishmania.
This disease is characterized by chronic skin le-
sions and leaves permanent scars as the deforma-
tion of the infected area [1]. CL is a public health
problem at a global level affecting 1.5million peo-
ple annually worldwide [1]. In Iran, the principal
pathogenic species of CL are Leishmania tropica
and Leishmania major [2]. The current first-line
chemotherapy of leishmaniasis with antimonial
drugs such as meglumine antimoniate and sodi-
um stibogluconate is a challenge due to having
the problems of emerging resistance, severe side
effects, or high costs [3]. Moreover, the second-
line drugs have some limitations for use because
of the prolonged length of therapy as well as ad-Mahmouverse reactions [4]. Since vaccines are not yet
available for CL, the maintenance and improve-
ment of the existing treatment regimens and dis-
covery initiatives have been found to be the only
ways of controlling this important tropical dis-
ease [5]. For decades plant extracts and plant-de-
rived compounds, due to having few side effects,
low cost, and high availability, have been valuable
sources that are commonly used to treat a wide
range of disease conditions including infectious
diseases [6]. The genus Pistacia belongs to the
family Anacardiaceae. Among the 15 known spe-
cies of pistachios, only three species grow in Iran,
which include Pistacia vera L., Pistacia khinjuk
Stocks ex Stocks, and Pistacia atlantica Desf. [7].
P. vera is the only species of the genus cultivated
commercially and the rest of the species are
mostly used as rootstocks for P. vera [8]. In folkdvand H et al. In Vitro and… Planta Med 2016; 82: 279–284
Table 1 Essential oil composition of P. vera identified by GC/MS.
No Components RIa % Compo-
sition
1. Tricyclene 956 1.24
2. α-Thujene 973 9.3
3. α-Pinene 987 18.1
4. Camphene 993 4.4
5. Sabinene 1017 0.6
6. β-Pinene 1026 3.1
7. β- Myrcene 1031 1.9
8. α-Terpinene 1035 1.6
9. Δ-2-Carene 1060 2.8
10. p-Cymene 1072 0.7
11. Limonene 1097 26.2
12. γ-Terpinene 1101 2.1
13. α-Terpinolene 1179 9.3
14. 1,8-Menthadien-5-ol 1184 1.1
15. 3-Cyclohexen 1196 1.3
16. α-Terpineol 1199 0.6
17. Borneol 1234 7.5
18. Thujopsene 1288 0.4
19. β-Himachalene 1297 0.7
20. Cembrene 1354 0.9
21. E-Caryophyllene 1428 2.1
22. Bis(2-ethylhexyl) phthalate 1448 0.6
23. 1,13-Teridecadiene 1498 0.6
24. delta-Cadinene 1581 0.6
25. Cyclohexadecane 1587 0.25
Total 97.93
a Retention indices on nonpolar DB-5 ms column in reference to n-alkanes
Table 2 The IC50 and CC50 values and SI determined for P. vera essential oil
and for meglumine antimoniate. The antileishmanial activity was determined
against intracellular amastigotes of L. tropica; the cytotoxicity was determined
on J7774 cells.
SIa CC50 (µg/mL) on
J774 cells (± SD)
IC50 (µg/mL) on
amastigotes (± SD)
Tested
material
10.1 216.3 ± 8.15 21.3 ± 2.1 Essential oil
27.5 1225.6 ± 11.1 44.6 ± 2.5 Meglumine
antimoniate
a CC50 for J774 cells/IC50 for amastigote forms of L. tropica
Table 3 Inhibition of the infection in macrophage cells after treatment of
L. tropica promastigotes with P. vera essential oil. Data are expressed as the
mean ± SD (n = 3).
Infectiveness
reduction
Percentage of infected
macrophages
Promastigotes
– 84.1 ± 3.5 Non-treated
77 ± 3.1 19.3 ± 1.2 Treated with essential
oil (5 µg/mL)
Table 4 Comparison of NO production in macrophage cells after treatment
with various concentrations of P. vera essential oil.
Production of nitric oxide (nM) Concentration
16 3.125
9.3 6.25
6 12.5
11 Non-treated
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l.medicine, different parts of P. vera including resin, leave, fruit,
and aerial parts are traditionally used for analgesic, carminative,
astringent, stomachic, aphrodisiac, antitussive, diuretic, and ex-
pectorant purposes [7]. Reviews have also reported that P. vera
has various biological activities such as anti-inflammatory, anti-
nociceptive, antiatherogenic, and hypoglycemic ones [9–11].
Moreover, in several studies, antibacterial, antiviral, antifungal,
and antiparasitic activities of this plant against several patho-
genic strains have been proven [12,13]. The major chemical con-
stituents of P. vera essential oil are hydrocarbon and oxygenated
monoterpens such as α-pinene [14]. However, some factors such
as plant species and part, cultivar sex, geographical origin, har-
vesting time, and climatic conditions could affect the chemical
composition and functional activity of this plant [15]. The
present study aimed to evaluate the chemical composition of P.
vera essential oil and investigate its antileishmanial activities
against L. tropica and L. major in in vitro and in vitro models, re-
spectively.Results
!
l" Table 1 shows the results obtained by gas chromatography/
mass spectrometry (GC/MS) analysis of P. vera essential oil.
Twenty-five compounds were identified, which represented
97.9% of the total oil. The main components were limonene
(26.2%), α-pinene (18.1%), α-thujene (9.3%), and α-terpinolene
(9.3%).
The findings demonstrated that P. vera essential oil inhibited the
growth rate of intramacrophage amastigotes of L. tropica as a
dose-dependent response. The obtained IC50 values were 21.3 ±Mahmoudvand H et al. In Vitro and… Planta Med 2016; 82: 279–2842.05 and 44.6 ± 2.5 µg/mL for the P. vera essential oil and meglu-
mine antimoniate, respectively (l" Table 2). The findings demon-
strated that the promastigote forms of L. tropica with no drugs
were able to infect 84.1% of the macrophage cells, while promas-
tigotes treated with P. vera essential oil had a potency to infect
only 19.3% of the macrophages cells (l" Table 3). These results in-
dicate that the infectivity of promastigotes of L. tropica is signifi-
cantly (p < 0.05) reduced after incubation with P. vera essential
oil. The findings also exhibited that the essential oil of P. vera trig-
gered the production of 16 µM of nitric oxide (NO) at the low con-
centration of 3.125 µg/mL compared to 11 µM for the untreated
macrophages. In contrast, the essential oil at a higher concentra-
tion (≥ 6.25 µg/mL) reduced the production of NO to 6 µM com-
pared to the untreated macrophages (l" Table 4). Moreover, the
in vitro assay demonstrated that P. vera essential oil had no signif-
icant cytotoxicity in J774 cells. The cytotoxic concentration for
50% of the cells (CC50) value of the essential oil was 216.3 ±
8.15 µg/mL. In addition, the selectivity index (SI) of greater than
10 for P. vera essential oil represented its safety to the macro-
phages and specificity to the parasite (l" Table 2).
The findings demonstrated that in the infected mice treated with
30mg/mL of P. vera essential oil, the number of parasites was sig-
nificantly (p < 0.05) decreased compared to the untreated mice,
while 10 and 20mg/mL of the essential oil reduced the number
of parasites in a dose-dependent manner (l" Fig. 1). The un-
treated group did not show any decrease in the number of para-
sites. After 30 days of treatment, 87.5% recovery (seven cases)
was observed in the cases treated with 30mg/mL essential oil,
Fig. 1 Comparison of mean number of parasites (parasite load) in in-
fected mice after treatment with various concentrations of P. vera essential
oil.
Fig. 2 Comparison of the healing rate of lesions in infected mice after
treatment with various concentrations of P. vera essential oil. (Color figure
available online only.)
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l.whereas with 10 and 20mg/mL of P. vera essential oil, 25 and 50%
recovery was observed, respectively (l" Fig. 2). The mean diame-
ter of the lesions decreased by 0.11 and 0.27 cm after the treat-
ment of the groups with concentrations of 10 and 20mg/mL of
P. vera essential oil, respectively. In the group treated with P. vera
essential oil at the concentration of 30mg/mL, the mean diame-
ter of the lesions decreased by 0.56 cm, while in the untreated
group, the mean diameter of the lesions increased by 1.01 cm
(l" Table 5).Discussion
!
Natural products, either as pure compounds or as standardized
extracts, provide unlimited opportunities for new drug discov-
eries because of the unmatched availability of chemical diversity
[16]. According to the World Health Organization (WHO), more
than 80% of the worldʼs population relies on traditional medicine
for their primary health care needs. In the past decades, the ad-
vent of synthetic antimicrobial drugs has caused reluctance in
plants as a rich resource of antimicrobial agents [17]. However,
in recent years, the emergence of some limitations in the use of
these drugs has caused changes in the situation of and interestin the field of ethnobotanical research [18]. In this study, the in
vitro and in vivo antileishmanial effects of P. vera essential oil
against L. tropica and L. major were investigated. In the in vitro
assay, P. vera essential oil significantly reduced the mean infec-
tion rate and subsequently the viability of amastigote forms of L.
tropica in the macrophages. In line with the present work, Orhan
et al. [12] reported that P. vera branch extract with a 4.8 µg/mL
concentration significantly inhibited (77.3%) the growth of L. do-
novani, whereas the dry leaf extract (PV‑DL) was active against
Plasmodium falciparum (60.6% inhibition). They also indicated
that the IC50 values of these extracts were 2.3 µg/mL for the
amastigotes of L. donovani grown in axenic culture and 3.65 µg/
mL for P. falciparum [12]. Of course, it should be noted that this
difference in susceptibility of amastigote stages between the
present study and the study conducted by Orhan et al. [12] might
be due to the use of extracellular amastigotes of L. donovani
grown in axenic culture, while in this investigation we used in-
tramacrophage amastigotes.
In the in vivo assay, the results demonstrated that 30mg/mL of
the essential oil had potent suppression effects on the CL in male
BALB/c mice infected with L. major (87.5% recovery), while 10
and 20mg/mL resulted in a weak and moderate suppression, re-
spectively. Since NO produced inmacrophages plays a pivotal role
as a leishmanicidal agent, in this survey we evaluated NO prod-
uction in macrophages exposed to various concentrations of P.
vera essential oil. The results obtained showed that the essential
oil of P. vera triggered the production of NO at the low concentra-
tion, but in higher concentrations, it reduced the production of
NO compared to the untreated macrophages.
The phytochemical screening of P. vera essential oil showed the
presence of terpenoids, phenols, and flavonoids in this plant [7].
Furthermore, the chemical composition of P. vera essential oil us-
ing GC/MS revealed that the main components were limonene
(26.21%), α-pinene (18.07%), α-thujene (9.31%), and α-terpino-
lene (9.28%). Therefore, the plant analyzed in this research was a
new chemotype of P. vera. It has been previously proven that the
chemical composition of essential oils depends on species, cli-
mate, collection time, and growth stage, altering the studied bio-
logical activities [15].
So far, individual activities of these compounds have been dem-
onstrated [17]. Furthermore, in various studies, potent antileish-
manial activities of these compounds, such as terpenic derivates,
carvacrol, p-cymene, thymol, carvone, limonene, and terpinene,
have been demonstrated [19–22]. Therefore, phytoconstituents
in these plants could be responsible for their antileishmanial ac-
tivity although their exact mode of action is poorly understood.
However, in the case of the antimicrobial mechanism of some ter-
penoid compounds such asmonoterpens, themain component of
P. vera, Sikkema et al. [23] revealed that they are diffused into
pathogens and damage cell membrane structures. On the other
hand, other reports have suggested that the antimicrobial activ-
ity is related to the ability of terpenes in affecting not only per-
meability but also other functions of cell membranes; these com-
pounds might cross the cell membranes, penetrate into the inte-
rior of the cell, and interact with critical intracellular sites [24,
25].
In the case of cytotoxic effects, it was found that P. vera essential
oil had no cytotoxic effects on J774 cells. The SI value ≥ 10 of the
essential oil showed its safety to the macrophages and specificity
to parasites [26]. Similar to the present findings, Orhan et al. [12]
showed that P. vera extract did not exert any cytotoxic effect on
mammalian L6 cells, even at very high concentrations. Therefore,Mahmoudvand H et al. In Vitro and… Planta Med 2016; 82: 279–284
Table 5 Effects of P. vera essential
oil on the size of lesions in BALB/c
mice infected by L. major.
p value Size of lesions (cm) after
treatment (30 days) (± SD)
Size of lesions (cm)
before treatment (± SD)
Concentra-
tions (mg/mL)
< 0.05 1.16 ± 0.3 1.27 ± 0.3 10
< 0.05 1.04 ± 0.2 1.31 ± 0.3 20 Essential oil
< 0.05 0.77 ± 0.2 1.33 ± 0.3 30
< 0.05 0.42 ± 0.1 1.37 ± 0.2 30 Meglumine
antimoniate
– 2.40 ± 0.2 1.39 ± 0.25 – Control
282 Original Papersit can be suggested that P. vera essential oil is safe for mammalian
cells.
To conclude, the present study found that P. vera essential oil
showed in vitro and in vivo effectiveness against L. tropica and
L. major, respectively. The findings of this study also provide sci-
entific evidence that natural plants could be used in traditional
medicine for the prevention and treatment of CL.D
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l.Materials and Methods
!
Chemicals
Meglumine antimoniate (Glucantime®, 99% purity), used as the
control drug (1.5 g/5mL) of antileishmanial activity, was pur-
chased from Aventis. Penicillin and streptomycin were obtained
from Alborz Pharmacy and were stored at room temperature
(25°C) until testing. MTT powder [3-(4.5-dimethylthiazol-2-yl)-
2.5-diphenyl tetrazolium bromide)], fetal calf serum (FCS),
RPMI-1640 medium with L-glutamine, and Griess reagent (A
and B) were purchased from Sigma-Aldrich. All of the other
chemicals and solvents used were of the highest purity commer-
cially available.
Collection of plant materials
The plant materials (branch) were collected from rural regions of
Kerman province, south east of Iran, from May to September
2013. They were identified by a botanist (Dr. Sharififar) of the
Botany Department of Shahid Bahonar University, Kerman, Iran.
A voucher specimen of the plant materials was deposited at the
Herbarium of Department of Pharmacognosy of School of Phar-
macy, Kerman University of Medical Science, Iran (KF 1136). The
collection of plant materials in this study was carried out on pri-
vate land, and no specific permissions were required for this lo-
cation. In addition, we confirmed that the present field study did
not involve endangered or protected species.
Isolation of essential oil
One hundred g of powdered plant materials (branch) were sub-
jected to hydrodistillation for 3 h using an all-glass clevenger-
type apparatus. The essential oil obtained was dried over anhy-
drous sodium sulfate and stored in darkness at 4°C in airtight
glass vials closed under nitrogen gas until testing [27].
Drug dilutions
To prepare the dilutions of the P. vera essential oil, 0.1mL of the
essential oil was dissolved in 0.97mL of normal saline. In addi-
tion, to enhance the dispersal of the essential oil in normal saline,
0.03mL of Tween 20 was added to the test tube. The resulting so-
lution was mixed adequately by a magnetic stirrer. Serial dilu-
tions were carried out to obtain the essential oil at concentra-
tions of 3.125 to 100 µg/mL. The selection of dilutions of P. veraMahmoudvand H et al. In Vitro and… Planta Med 2016; 82: 279–284essential oil were based on initial experiments, which also
showed that normal saline plus Tween 20 did not cause an effect
on the growth of parasites.
Gas chromatography/mass spectrometry analysis
of essential oil
In this study, GC analysis was carried out by a Hewlett-Packard
6890 with an HP-5MS column (30mm×0.25mm, film thickness
0.25mm). The column temperature was maintained at 55°C for
3min and programmed to 180°C at a rate of 5°C per min, and
kept constant at 220°C for 5min. Injector and interface temper-
atures were 220°C and 290°C, respectively. The flow rate of heli-
um as a carrier gas was 1mL/min C.F. The percentages were cal-
culated by electronic integration of FID peak areas without the
use of response factors correction. Linear retention indices for all
components were determined by coinjection of the samples with
a solution containing a homologous series of C8-C22 n-alkanes.
GC/MS analysis was performed using a Thermoquest-Finnigan
gas chromatograph equippedwith fused silica capillary DB-5 col-
umn (30mm×0.25mm, film thickness 0.25mm) coupled with a
TRACE mass. Helium was used as a carrier gas with an ionization
voltage of 70 eV. Ion source and interface temperatures were
220°C and 290°C, respectively. The mass range was from 40 to
400 u. The oven temperature program was the same as above for
the GC.
Identification of the essential oil components
The components of the essential oil were identified by compari-
son of their retention indices and mass spectra with those of the
standards of the Wiley 2001 library data of the GC/MS system or
with those reported in the literature [28].
Parasite and cell culture
Reference strains of L. tropica (MHOM/IR/2002/Mash2) and L.
major (MRHO/IR/75/ER) were kindly provided by the Center for
Research and Training in Skin Diseases and Leprosy (Tehran,
Iran). The parasites were cultured in NNN medium and subcul-
tured in RPMI 1640 supplemented with penicillin (200 IU/mL),
streptomycin (100 µg/mL), and 15% heat-inactivated FCS. The
murine macrophage cell line (J774-A1) was obtained from the
Pasteur Institute of Iran (Tehran, Iran). The cells were cultured
and maintained in Dulbeccoʼs modified Eagleʼs medium (DMEM)
supplemented with 10% FBS at 37°C in 5% CO2.
In vitro antileishmanial activity
Anti-amastigote assay: The intracellular amastigote assay with
the P. vera essential oil was carried out according to the method
described elsewhere [29]. Briefly, before adding themacrophages
to the plates, 1 cm2 cover slips were placed in the wells of 6-
chamber slides (Lab-Tek, Nalge Nunc International). In the next
step, 200 µL of macrophage cells (105/mL) were incubated at 37°
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l.C in 5% CO2 for 2 h in DMEM. Then, 200 uL of L. tropica promasti-
gotes (106/mL) in the stationary phase were added to the murine
macrophages so that proportion of Leishmania/macrophage was
10:1 and were incubated again in a similar condition for 24 h.
Free parasites were removed by washing with RPMI 1640 me-
dium and the infected macrophages were treated with 50 µL of
various concentrations of essential oil (0–100 µg/mL) at 37°C in
5% CO2 for 72 h. At the end, the dried slides were fixed with
methanol, stained by Giemsa, and observed under a light micro-
scope. Also, the macrophages containing amastigotes without ex-
tract and those with no parasite and extract were considered
positive and negative controls, respectively. Activity of the essen-
tial oil on intracellular amastigotes was evaluated by counting the
number of amastigotes in each macrophage by examining 100
macrophages in comparison with those obtained with the posi-
tive control. The 50% inhibitory concentrations (IC50 values) were
measured for all of the tested drugs by the Probit test in SPSS
software. All of the tests were performed in triplicate.
Inhibition of infection in macrophage cells: To determine the in-
hibitory effect of P. vera essential oil against the promastigote in-
vasion of macrophages, promastigotes of L. tropica (106/mL) were
preincubated in essential oil (5 µg/mL) for 2 h at room tempera-
ture (the selection of 5 µg/mL was based on the initial experi-
ments which showed no significant effect on viability of promas-
tigote cells). Then, promastigotes were washed with RPMI-1640
medium and incubated with murine macrophages (J774 cells)
for 4 h. After washing the cells again, the macrophages were
stained by Giemsa and studied by a light microscope to evaluate
the frequency of infection by counting 100 macrophages [30]. All
of the tests were performed in triplicate.
Nitric oxide production determination: NO release in the superna-
tants of the macrophage culture was measured by the Griess re-
action for nitrites. The supernatants (100 µL) were collected 72 h
after introducing the P. vera essential oil into the culturemedium.
The assay was done in triplicate wells in a 96-well tissue culture
plate. To this, 60 µL of Griess reagent A and then 60 µL of Griess
reagent Bwere added. The plateswere read at 540 nm in an ELISA
plate reader (BioTek-ELX800).
Cytotoxic effects: Cytotoxicity effects of P. vera essential oil against
J774-A1 cells were evaluated by cultivating macrophages (5 ×
105) with various concentrations of essential oil (0 to 500 µg/mL)
in 96-well tissue culture plates at 37°C in 5% CO2 for 48 h. Cell vi-
ability was determined by the colorimetric MTT assay and the re-
sults are displayed as the percentage of dead cells compared to
non-treated macrophages (100% of viability). Moreover, CC50
was calculated by the Probit test in SPSS software [31].
Selectivity index: SI, calculated based on the equation of CC50 for
murine macrophage cells/IC50 for amastigote forms of L. tropica,
was used to compare toxicity and activity of P. vera essential oil
as described by Weniger et al. [26].
In vivo antileishmanial activity
Ethical statement: This study was carried out in strict accordance
with the recommendations of the Guide for Care and Use of Lab-
oratory Animals of National Institutes of Health. The protocol was
approved by the Committee on Ethics of Animal Experiments,
Lorestan University of Medical Sciences (Permit number: 91/27,
2013).
Animals: Forty male BALB/c mice (6–8 weeks old) were obtained
from the Animal Breeding Stock Facility, Razi Institute of Iran
(Karaj, Iran). They were housed in a colony room with a 12-h/12-h light/dark cycle at 21 ± 2°C and handled according to the
standard protocols for the use of laboratory animals [32].
Induction of cutaneous leishmaniasis in BALB/c mice: In this study,
male BALB/c mice were infected subcutaneously with 0.1mL of
promastigotes of L. major (2 × 106 cells/mL) harvested from the
stationary phase at the base of the tail [33]. The mice were ran-
domly divided into five groups and each group contained eight
mice.
Treatment of infected mice: The infected mice were treated after 5
weeks when leishmanial lesions appeared. At first, the diameter
of the lesions was measured before the treatment. Then, the lo-
tion of essential oil with concentrations of 10, 20, and 30mg/mL
was applied by rubbing to each tested group on a daily basis for
30 days. The positive control group received meglumine anti-
moniate (30mg/kg) as an intralesional injection. Before and after
the treatment, the diameter of the lesions was measured (lesion
borders) using a vernier caliperand to determine the number of
parasites. Impression smears were prepared from the lesions,
dried in air, fixed by methanol, and stained with Giemsa to spec-
ify the load of parasites by light microscopy [34].
Statistical analysis
Data analysis was carried out using SPSS statistical package ver-
sion 17.0 (SPSS, Inc.). Differences between the test and control
groups were analyzed by a t-test. In addition, p < 0.05 was consid-
ered statistically significant.Acknowledgments
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